Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

Scientists are designing mRNA vaccines to produce virus-like nanoparticles, which should lead to a more robust immune ...

When U.S. Health Secretary Robert F. Kennedy Jr. announced on Aug. 5 that nearly $500 million to research mRNA vaccines would be canceled, it was one in a continuing line of moves that have put his ...

A new study suggests that these vaccines might boost the effects of immunotherapy drugs, perhaps by alerting the immune ...

A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...

WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

Moderna Inc. (NASDAQ: MRNA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...